|
1
|
Chen S, Zhou D, Yu J, Ruan R, Liu Y, Li Y,
Shen Q and Wang S: A novelly developed bipolar needle knife can be
an alternative device choice for endoscopic submucosal dissection
(with video). Front Med (Lausanne). 9:8886352022. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Li D, Wang R, Wu N and Yu Y: LncRNA HULC
as a potential predictor of prognosis and clinicopathological
features in patients with digestive system tumors: A meta-analysis.
Aging (Albany NY). 14:1797–811. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu T, Song C, Zhang Y, Siyin ST, Zhang Q,
Song M, Cao L and Shi H: Hepatitis B virus infection and the risk
of gastrointestinal cancers among Chinese population: A prospective
cohort study. Int J Cancer. 150:1018–1028. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang R, Lai Q, Tang L, Tao Y, Yao Y, Liu
Y, Lu Y, Shen C, Lu R, Fan C, et al: A novel 5T4-targeting
antibody-drug conjugate H6-DM4 exhibits potent therapeutic efficacy
in gastrointestinal tumor xenograft models. Am J Cancer Res.
8:610–623. 2018.PubMed/NCBI
|
|
6
|
Ji J, Wang Z, Sun W, Li Z, Cai H, Zhao E
and Gui H: Effects of cynaroside on cell proliferation, apoptosis,
migration and invasion though the MET/AKT/mTOR axis in gastric
cancer. Int J Mol Sci. 22:121252021. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
You X, Wu J, Zhao X, Jiang X, Tao W, Chen
Z, Huang C, Zheng T and Shen X: Fibroblastic galectin-1-fostered
invasion and metastasis are mediated by TGF-β1-induced
epithelial-mesenchymal transition in gastric cancer. Aging (Albany
NY). 13:18464–18481. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Seidlitz T, Chen YT, Uhlemann H, Schölch
S, Kochall S, Merker SR, Klimova A, Hennig A, Schweitzer C, Pape K,
et al: Mouse models of human gastric cancer subtypes with
stomach-specific CreERT2-mediated pathway alterations.
Gastroenterology. 157:1599–1614.e2. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lyons K, Le LC, Pham YTH, Borron C, Park
JY, Tran CTD, Tran TV, Tran HT, Vu KT, Do CD, et al: Gastric
cancer: epidemiology, biology, and prevention: A mini review. Eur J
Cancer Prev. 28:397–412. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferlay J, Steliarova-Foucher E,
Lortet-Tieulent J, Rosso S, Coebergh JW, Comber H, Forman D and
Bray F: Cancer incidence and mortality patterns in Europe:
Estimates for 40 countries in 2012. Eur J Cancer. 49:1374–1403.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yao Y, Sun S, Gu J, Ni H, Zhong K, Xu Q,
Zhou D, Wang X, Gao L and Zhu X: Roux-en-Y reconstruction
alleviates radical gastrectomy-induced colitis via down-regulation
of the butyrate/NLRP3 signaling pathway. EBioMedicine.
86:1043472022. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lee SD, Yu D, Lee DY, Shin HS, Jo JH and
Lee YC: Upregulated microRNA-193a-3p is responsible for cisplatin
resistance in CD44(+) gastric cancer cells. Cancer Sci.
110:662–673. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kim SH, Jin H, Meng RY, Kim DY, Liu YC,
Chai OH, Park BH and Kim SM: Activating Hippo pathway via rassf1 by
ursolic acid suppresses the tumorigenesis of gastric cancer. Int J
Mol Sci. 20:47092019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Malloy J, Zhuang D, Kim T, Inskeep P, Kim
D and Taylor K: Single and multiple dose evaluation of a novel
MetAP2 inhibitor: Results of a randomized, double-blind,
placebo-controlled clinical trial. Diabetes Obes Metab.
20:1878–1884. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kamin Mukaz D, Gergi M, Koh I, Zakai NA,
Judd SE, Sholzberg M, Baumann Kreuziger L, Freeman K, Colovos C,
Olson NC and Cushman M: Thrombo-inflammatory biomarkers and D-dimer
in a biracial cohort study. Res Pract Thromb Haemost. 5:e126322021.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ho-Tin-Noé B, Goerge T and Wagner DD:
Platelets: Guardians of tumor vasculature. Cancer Res.
69:5623–6526. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Elyamany G, Alzahrani AM and Bukhary E:
Cancer-associated thrombosis: An overview. Clin Med Insights Oncol.
8:129–137. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rickles FR and Falanga A: Activation of
clotting factors in cancer. Cancer Treat Res. 148:31–41. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Demers M, Krause DS, Schatzberg D,
Martinod K, Voorhees JR, Fuchs TA, Scadden DT and Wagner DD:
Cancers predispose neutrophils to release extracellular DNA traps
that contribute to cancer-associated thrombosis. Proc Natl Acad Sci
USA. 109:13076–13081. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Fukumoto K, Taniguchi T, Usami N,
Kawaguchi K, Fukui T, Ishiguro F, Nakamura S and Yokoi K:
Preoperative plasma D-dimer level is an independent prognostic
factor in patients with completely resected non-small cell lung
cancer. Surg Today. 45:63–37. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Liu L, Zhang X, Yan B, Gu Q, Zhang X, Jiao
J, Sun D, Wang N and Yue X: Elevated plasma D-dimer levels
correlate with long term survival of gastric cancer patients. PLoS
One. 9:e905472014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guan Y, Xu B, Sui Y, Chen Z, Luan Y, Jiang
Y, Wei L, Long W, Zhao S, Han L, et al: Pan-cancer analysis and
validation reveals that D-dimer-related genes are prognostic and
downregulate CD8+ T cells via TGF-beta signaling in
gastric cancer. Front Mol Biosci. 9:7907062022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Dai H, Zhou H, Sun Y, Xu Z, Wang S, Feng T
and Zhang P: D-dimer as a potential clinical marker for predicting
metastasis and progression in cancer. Biomed Rep. 9:453–457.
2018.PubMed/NCBI
|
|
25
|
Suzuki T, Shimada H, Nanami T, Oshima Y,
Yajima S, Ito M, Washizawa N and Kaneko H: Hyperfibrinogenemia is
associated with inflammatory mediators and poor prognosis in
patients with gastric cancer. Surg Today. 46:1394–1401. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Go SI, Lee MJ, Lee WS, Choi HJ, Lee US,
Kim RB, Kang MH, Kim HG, Lee GW, Kang JH, et al: D-dimer can serve
as a prognostic and predictive biomarker for metastatic gastric
cancer treated by chemotherapy. Medicine (Baltimore). 94:e9512015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kim EY and Song KY: Prognostic value of
D-dimer levels in patients with gastric cancer undergoing
gastrectomy. Surg Oncol. 37:1015702021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liang Y, He D, Wu L, Ding X, Wang X, Wang
B, Zhang R and Liang H: Elevated preoperative plasma D-dimer dose
not adversely affect survival of gastric cancer after gastrectomy
with curative intent: A propensity score analysis. Chin J Cancer
Res. 30:254–262. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Edge SB and Compton CC: The american joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Coccolini F, Montori G, Ceresoli M, Cima
S, Valli MC, Nita GE, Heyer A, Catena F and Ansaloni L: Advanced
gastric cancer: What we know and what we still have to learn. World
J Gastroenterol. 22:1139–1159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen L, Huang Y, Sun M, Xu H, Wei W and Wu
W: Clinicopathological features associated with lymph node
metastasis in early gastric cancer: Analysis of a
single-institution experience in China. Can J Gastroenterol.
23:353–356. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Asakawa Y, Ohtaka M, Maekawa S, Fukasawa
M, Nakayama Y, Yamaguchi T, Inoue T, Uetake T, Sakamoto M, Sato T,
et al: Stratifying the risk of lymph node metastasis in
undifferentiated-type early gastric cancer. World J Gastroenterol.
21:2683–2692. 2015. View Article : Google Scholar : PubMed/NCBI
|
